Ji, G., Guo, Q., Xue, Q., Kong, R., Wang, S., Lei, K., . . . Wang, X. (2021). Novel GPR120 Agonists with Improved Pharmacokinetic Profiles for the Treatment of Type 2 Diabetes. MDPI AG.
Cita Chicago Style (17a ed.)Ji, Guoxia, Qinghua Guo, Qidi Xue, Ruifang Kong, Shiben Wang, Kang Lei, Renmin Liu, y Xuekun Wang. Novel GPR120 Agonists with Improved Pharmacokinetic Profiles for the Treatment of Type 2 Diabetes. MDPI AG, 2021.
Cita MLA (8a ed.)Ji, Guoxia, et al. Novel GPR120 Agonists with Improved Pharmacokinetic Profiles for the Treatment of Type 2 Diabetes. MDPI AG, 2021.
Precaución: Estas citas no son 100% exactas.